NYSEAMERICAN : LCTX
Lineage Cell Therapeutics, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 1 USD (Oct 30, 2026, 10:19 AM EDT) · Market cap 252.91M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Lineage Cell Therapeutics, Inc. (LCTX) reported revenue of 13.08M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 13.08M | 14.56M | 9.50M | 8.95M | 14.70M | 4.34M |
| Cost of Revenue | 20.59M | 17.88M | 12.81M | 16.38M | 728.00K | 1.43M |
| Gross Profit | -7.50M | -3.32M | -3.31M | -7.43M | 13.97M | 2.92M |
| Selling, General & Admin | 19.34M | 18.46M | 18.17M | 13.77M | 22.51M | 18.21M |
| Research & Development | 13.99M | 33.91M | ||||
| Operating Expenses | 19.34M | 18.46M | 18.17M | 13.77M | 36.49M | 52.13M |
| Operating Income | -26.85M | -21.78M | -21.48M | -21.20M | -22.52M | -49.21M |
| Interest & Investment Income | 1.54M | 1.69M | 1.72M | 1.63M | 829.00K | 2.00K |
| Currency Exchange Gain (Loss) | 1.42M | 2.15M | -269.00K | -1.04M | -2.00M | 1.49M |
| Other Non Operating Income (Expenses) | -13.52M | -35.86M | 1.46M | 542.00K | 73.00K | 205.00K |
| EBT Excluding Unusual Items | -37.41M | -53.80M | -18.57M | -20.08M | -23.62M | -47.52M |
| Gain (Loss) on Sale of Investments | 23.00K | -8.00K | -8.00K | -176.00K | -2.19M | 3.73M |
| Asset Writedown | -14.84M | |||||
| Legal Settlements | -3.53M | |||||
| Other Unusual Items | 500.00K | 523.00K | ||||
| Pretax Income | -37.38M | -68.65M | -18.58M | -23.28M | -25.81M | -43.27M |
| Income Tax Expense | -5.28M | -5.28M | -1.80M | 541.00K | ||
| Earnings From Continuing Operations | -32.10M | -63.37M | -18.58M | -21.48M | -26.35M | -43.27M |
| Minority Interest in Earnings | -155.00K | -166.00K | -27.00K | -7.00K | 80.00K | 251.00K |
| Net Income | -32.26M | -63.53M | -18.61M | -21.49M | -26.27M | -43.02M |
| Net Income to Common | -32.26M | -63.53M | -18.61M | -21.49M | -26.27M | -43.02M |
| Shares Outstanding (Basic) | 240.15M | 230.12M | 200.19M | 172.66M | 169.79M | 164.50M |
| Shares Outstanding (Diluted) | 240.15M | 230.12M | 200.19M | 172.66M | 169.79M | 164.50M |
| EPS (Basic) | -0.13 | -0.28 | -0.09 | -0.12 | -0.15 | -0.26 |
| EPS (Diluted) | -0.19 | -0.28 | -0.09 | -0.12 | -0.15 | -0.26 |
| Free Cash Flow | -24.39M | -19.44M | -23.66M | -29.24M | 646.00K | -23.90M |
| Free Cash Flow Per Share | -0.10 | -0.08 | -0.12 | -0.17 | 0.00 | -0.14 |
| Gross Margin | -57.36% | -22.80% | -34.81% | -83.07% | 95.05% | 67.15% |
| Operating Margin | -205.23% | -149.62% | -226.11% | -237.04% | -153.17% | -1,133.63% |
| Profit Margin | -246.58% | -436.47% | -195.91% | -240.20% | -178.69% | -990.99% |
| Free Cash Flow Margin | -186.42% | -133.56% | -249.05% | -326.89% | 4.39% | -550.59% |
| EBITDA | -26.11M | -21.08M | -20.87M | -20.51M | -21.79M | -48.34M |
| EBITDA Margin | -199.58% | -144.82% | -219.70% | -229.30% | -148.22% | |
| D&A For EBITDA | 739.00K | 699.00K | 609.00K | 692.00K | 727.00K | 873.00K |
| EBIT | -26.85M | -21.78M | -21.48M | -21.20M | -22.52M | -49.21M |
| EBIT Margin | -205.23% | -149.62% | -226.11% | -237.04% | -153.17% | |
| Revenue as Reported | 13.08M | 14.56M | 9.50M | 8.95M | 14.70M | 4.34M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 37.35M | 40.79M | 45.79M | 35.44M | 11.36M | 55.74M |
| Short-Term Investments | 13.47M | 14.99M | 2.02M | 50.00K | 46.52M | 2.62M |
| Cash & Short-Term Investments | 50.83M | 55.78M | 47.80M | 35.49M | 57.88M | 58.36M |
| Accounts Receivable | 956.00K | 1.56M | 638.00K | 745.00K | 297.00K | 50.84M |
| Receivables | 956.00K | 1.56M | 638.00K | 745.00K | 297.00K | 50.84M |
| Prepaid Expenses | 1.16M | 1.79M | 2.55M | 2.20M | 1.83M | 2.35M |
| Other Current Assets | 22.50K | 22.50K | ||||
| Total Current Assets | 52.97M | 59.16M | 51.00M | 38.44M | 60.00M | 111.55M |
| Property, Plant & Equipment | 4.48M | 4.70M | 4.39M | 4.77M | 5.67M | 4.87M |
| Goodwill | 10.67M | 10.67M | 10.67M | 10.67M | 10.67M | 10.67M |
| Other Intangible Assets | 31.70M | 31.70M | 46.54M | 46.56M | 46.69M | 46.82M |
| Long-Term Deferred Tax Assets | 5.80M | 5.80M | ||||
| Other Long-Term Assets | 598.00K | 558.00K | 614.00K | 577.00K | 627.00K | 630.00K |
| Total Assets | 106.22M | 112.58M | 113.22M | 101.02M | 123.66M | 174.54M |
| Accounts Payable | 1.54M | 2.34M | 1.17M | 2.05M | 2.39M | 3.54M |
| Accrued Expenses | 3.85M | 4.84M | 4.26M | 4.22M | 6.21M | 24.25M |
| Current Portion of Leases | 951.00K | 853.00K | 1.15M | 882.00K | 952.00K | 831.00K |
| Current Unearned Revenue | 1.68M | 3.33M | 7.39M | 10.81M | 9.42M | 18.12M |
| Other Current Liabilities | 375.00K | |||||
| Total Current Liabilities | 8.02M | 11.37M | 13.98M | 17.96M | 18.98M | 47.12M |
| Long-Term Leases | 1.35M | 1.57M | 1.36M | 2.07M | 2.94M | 1.97M |
| Long-Term Unearned Revenue | 12.34M | 12.38M | 14.43M | 18.69M | 27.73M | 32.45M |
| Long-Term Deferred Tax Liabilities | 22.00K | 22.00K | 273.00K | 273.00K | 2.08M | 2.08M |
| Other Long-Term Liabilities | 24.70M | 43.91M | 6.16M | 2.00K | 30.00K | |
| Total Liabilities | 46.42M | 69.24M | 36.21M | 39.00M | 51.73M | 83.65M |
| Common Stock | 535.72M | 515.47M | 484.72M | 451.34M | 440.28M | 434.53M |
| Retained Earnings | -470.33M | -467.00M | -403.46M | -384.86M | -363.37M | -337.10M |
| Comprehensive Income & Other | -4.47M | -3.92M | -2.88M | -3.07M | -3.57M | -5.21M |
| Total Common Equity | 60.92M | 44.55M | 78.38M | 63.42M | 73.34M | 92.22M |
| Minority Interest | -1.12M | -1.20M | -1.37M | -1.40M | -1.40M | -1.32M |
| Shareholders' Equity | 59.80M | 43.35M | 77.01M | 62.02M | 71.94M | 90.90M |
| Total Liabilities & Equity | 106.22M | 112.58M | 113.22M | 101.02M | 123.66M | 174.54M |
| Total Debt | 2.30M | 2.42M | 2.51M | 2.95M | 3.90M | 2.80M |
| Net Cash (Debt) | 48.53M | 53.36M | 45.29M | 32.54M | 53.98M | 55.56M |
| Net Cash Per Share | 0.20 | 0.23 | 0.23 | 0.19 | 0.32 | 0.34 |
| Filing Date Shares Outstanding | 252.91M | 249.09M | 228.36M | 188.53M | 170.15M | 169.71M |
| Total Common Shares Outstanding | 252.91M | 243.12M | 220.42M | 174.99M | 170.09M | 169.48M |
| Working Capital | 44.95M | 47.79M | 37.02M | 20.48M | 41.02M | 64.43M |
| Book Value Per Share | 0.24 | 0.18 | 0.36 | 0.36 | 0.43 | 0.54 |
| Tangible Book Value | 18.54M | 2.18M | 21.17M | 6.18M | 15.97M | 34.73M |
| Tangible Book Value Per Share | 0.07 | 0.01 | 0.10 | 0.04 | 0.09 | 0.20 |
| Machinery | 5.39M | 5.28M | 4.13M | 3.61M | 3.26M | 3.47M |
| Leasehold Improvements | 3.00M | 2.75M | 2.30M | 2.31M | 2.15M | 2.54M |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -32.26M | -63.53M | -18.61M | -21.49M | -26.27M | -43.02M |
| Depreciation & Amortization | 739.00K | 699.00K | 609.00K | 692.00K | 727.00K | 873.00K |
| Loss (Gain) From Sale of Assets | 31.00K | -11.00K | 24.00K | |||
| Asset Writedown & Restructuring Costs | 14.84M | |||||
| Loss (Gain) From Sale of Investments | -319.00K | -36.00K | -221.00K | -503.00K | 1.69M | -3.73M |
| Stock-Based Compensation | 5.07M | 4.75M | 5.08M | 4.64M | 4.29M | 3.72M |
| Other Operating Activities | 6.74M | 28.30M | -1.21M | -1.11M | 2.01M | -2.28M |
| Change in Accounts Receivable | -524.00K | -316.00K | 106.00K | -446.00K | 50.31M | -857.00K |
| Change in Accounts Payable | 678.00K | 2.27M | -1.68M | -2.29M | -18.70M | 21.64M |
| Change in Unearned Revenue | -3.99M | -6.11M | -7.68M | -7.64M | -13.35M | 380.00K |
| Change in Other Net Operating Assets | -137.00K | 46.00K | 489.00K | -418.00K | 446.00K | -72.00K |
| Operating Cash Flow | -23.82M | -18.92M | -23.09M | -28.57M | 1.06M | -23.56M |
| Capital Expenditures | -574.00K | -522.00K | -565.00K | -674.00K | -413.00K | -340.00K |
| Divestitures | 21.00K | |||||
| Investment in Securities | -13.14M | -12.94M | -1.74M | 47.12M | -45.75M | 10.06M |
| Investing Cash Flow | -13.71M | -13.46M | -2.31M | 46.45M | -46.16M | 9.74M |
| Long-Term Debt Repaid | -59.00K | -54.00K | -54.00K | -32.00K | -20.00K | |
| Net Debt Issued (Repaid) | -54.00K | -59.00K | -54.00K | -54.00K | -32.00K | -20.00K |
| Issuance of Common Stock | 32.57M | 27.71M | 36.10M | 6.51M | 796.00K | 38.10M |
| Repurchase of Common Stock | -41.00K | -16.00K | -23.00K | -37.00K | -17.00K | -54.00K |
| Other Financing Activities | -232.00K | -684.00K | -171.00K | 885.00K | -1.10M | |
| Financing Cash Flow | 32.24M | 26.95M | 35.86M | 6.42M | 1.63M | 36.93M |
| Foreign Exchange Rate Adjustments | 430.00K | 396.00K | -95.00K | -250.00K | -873.00K | -20.00K |
| Net Cash Flow | -4.86M | -5.03M | 10.36M | 24.06M | -44.34M | 23.09M |
| Free Cash Flow | -24.39M | -19.44M | -23.66M | -29.24M | 646.00K | -23.90M |
| Free Cash Flow Margin | -186.42% | -133.56% | -249.05% | -326.89% | 4.39% | -550.59% |
| Free Cash Flow Per Share | -0.10 | -0.08 | -0.12 | -0.17 | 0.00 | -0.14 |
| Levered Free Cash Flow | -14.77M | -11.18M | -12.80M | -10.37M | 13.34M | -37.46M |
| Unlevered Free Cash Flow | -14.77M | -11.18M | -12.80M | -10.37M | 13.34M | -37.46M |
| Cash Interest Paid | 8.00K | 29.00K | 9.00K | 10.00K | 13.00K | 13.00K |
| Change in Working Capital | -3.97M | -4.11M | -8.77M | -10.80M | 18.70M | 21.10M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 255.44M | 404.69M | 110.76M | 190.74M | 198.87M | 412.97M |
| Enterprise Value | 206.91M | 365.58M | 79.41M | 151.03M | 133.92M | 349.46M |
| Last Close Price | 1.01 | 1.67 | 0.50 | 1.09 | 1.17 | 2.45 |
| Forward PE | 45.62 | 45.62 | 45.62 | 45.62 | 45.62 | |
| PS Ratio | 19.52 | 27.80 | 11.66 | 21.32 | 13.53 | 95.13 |
| PB Ratio | 4.19 | 9.34 | 1.44 | 3.08 | 2.77 | 4.54 |
| P/TBV Ratio | 13.77 | 185.89 | 5.23 | 30.84 | 12.45 | 11.89 |
| P/FCF Ratio | 307.85 | |||||
| P/OCF Ratio | 187.79 | |||||
| EV/Sales Ratio | 15.81 | 25.11 | 8.36 | 16.88 | 9.11 | 80.50 |
| EV/FCF Ratio | 207.31 | |||||
| Debt / Equity Ratio | 0.04 | 0.06 | 0.03 | 0.05 | 0.05 | 0.03 |
| Debt / FCF Ratio | 6.03 | |||||
| Net Debt / Equity Ratio | -0.81 | -1.23 | -0.59 | -0.53 | -0.75 | -0.61 |
| Net Debt / EBITDA Ratio | 1.86 | 2.53 | 2.17 | 1.59 | 2.48 | 1.15 |
| Net Debt / FCF Ratio | 1.99 | 2.75 | 1.91 | 1.11 | -83.56 | 2.32 |
| Asset Turnover | 0.13 | 0.13 | 0.09 | 0.08 | 0.10 | 0.03 |
| Quick Ratio | 6.46 | 5.04 | 3.47 | 2.02 | 3.06 | 2.32 |
| Current Ratio | 6.61 | 5.20 | 3.65 | 2.14 | 3.16 | 2.37 |
| Return on Equity (ROE) | -60.06% | -105.30% | -26.73% | -32.07% | -32.37% | -46.52% |
| Return on Assets (ROA) | -17.04% | -12.06% | -12.53% | -11.80% | -9.44% | -21.77% |
| Return on Capital Employed (ROCE) | -27.30% | -21.50% | -21.60% | -25.50% | -21.50% | -38.60% |
| Earnings Yield | -18.37% | -15.70% | -16.80% | -11.27% | -13.21% | -10.42% |
| FCF Yield | -9.55% | -4.80% | -21.36% | -15.33% | 0.33% | -5.79% |
| Buyback Yield / Dilution | -8.73% | -14.95% | -15.94% | -1.69% | -3.22% | -9.64% |